Biomarker based adaptive development in Alzheimer disease (BioAdaptAD)
Flanders Innovation & Entrepreneurship
Alzheimer's disease & other dementias
The general objectives of this project are to develop a BACE inhibitor for disease modification in Alzheimer’s disease and to explore the development in an earlier prodromal Alzheimer’s disease population. From a drug development perspective, this will involve multiple adaptation steps and the intensive use of biomarkers.